<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Catusi I</submitter><funding>Ministero della Salute</funding><funding>Istituto Auxologico Italiano</funding><pagination>e1056</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6978242</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Chromosomal microarray analysis (CMA) is nowadays widely used in the diagnostic path of patients with clinical phenotypes. However, there is no ascertained evidence to date on how to assemble single/combined clinical categories of developmental phenotypic findings to improve the array-based detection rate.&lt;h4>Methods&lt;/h4>The Italian Society of Human Genetics coordinated a retrospective study which included CMA results of 5,110 Italian patients referred to 17 genetics laboratories for variable combined clinical phenotypes.&lt;h4>Results&lt;/h4>Non-polymorphic copy number variants (CNVs) were identified in 1512 patients (30%) and 615 (32%) present in 552 patients (11%) were classified as pathogenic. CNVs were analysed according to type, size, inheritance pattern, distribution am</pubmed_abstract><journal>Molecular genetics &amp; genomic medicine</journal><pubmed_title>Testing single/combined clinical categories on 5110 Italian patients with developmental phenotypes to improve array-based detection rate.</pubmed_title><pmcid>PMC6978242</pmcid><funding_grant_id>Ricerca Corrente 08C723_2017‐2019</funding_grant_id><funding_grant_id>Ricerca corrente 08C922_2019</funding_grant_id><pubmed_authors>Nardone AM</pubmed_authors><pubmed_authors>Recalcati MP</pubmed_authors><pubmed_authors>Alghisi A</pubmed_authors><pubmed_authors>Giagnacovo M</pubmed_authors><pubmed_authors>Zilio A</pubmed_authors><pubmed_authors>Tonelli M</pubmed_authors><pubmed_authors>Larizza L</pubmed_authors><pubmed_authors>Ceglia C</pubmed_authors><pubmed_authors>Bestetti I</pubmed_authors><pubmed_authors>Ceccarini C</pubmed_authors><pubmed_authors>Cappellani S</pubmed_authors><pubmed_authors>Marseglia G</pubmed_authors><pubmed_authors>Renieri A</pubmed_authors><pubmed_authors>Redaelli S</pubmed_authors><pubmed_authors>Valtorta C</pubmed_authors><pubmed_authors>D'Aprile A</pubmed_authors><pubmed_authors>Zuccarello D</pubmed_authors><pubmed_authors>Alfonsi M</pubmed_authors><pubmed_authors>Coviello D</pubmed_authors><pubmed_authors>Fabretto A</pubmed_authors><pubmed_authors>Casalone R</pubmed_authors><pubmed_authors>Ciaschini AM</pubmed_authors><pubmed_authors>Novelli A</pubmed_authors><pubmed_authors>Tiberi F</pubmed_authors><pubmed_authors>Crosti F</pubmed_authors><pubmed_authors>Montaldi A</pubmed_authors><pubmed_authors>Genesio R</pubmed_authors><pubmed_authors>Palka C</pubmed_authors><pubmed_authors>Caselli R</pubmed_authors><pubmed_authors>Postorivo D</pubmed_authors><pubmed_authors>Pessina C</pubmed_authors><pubmed_authors>Villa N</pubmed_authors><pubmed_authors>Giardino D</pubmed_authors><pubmed_authors>Pecile V</pubmed_authors><pubmed_authors>Malacarne M</pubmed_authors><pubmed_authors>Granata P</pubmed_authors><pubmed_authors>Rigon C</pubmed_authors><pubmed_authors>Garzo M</pubmed_authors><pubmed_authors>Catusi I</pubmed_authors><pubmed_authors>Longo I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Testing single/combined clinical categories on 5110 Italian patients with developmental phenotypes to improve array-based detection rate.</name><description>&lt;h4>Background&lt;/h4>Chromosomal microarray analysis (CMA) is nowadays widely used in the diagnostic path of patients with clinical phenotypes. However, there is no ascertained evidence to date on how to assemble single/combined clinical categories of developmental phenotypic findings to improve the array-based detection rate.&lt;h4>Methods&lt;/h4>The Italian Society of Human Genetics coordinated a retrospective study which included CMA results of 5,110 Italian patients referred to 17 genetics laboratories for variable combined clinical phenotypes.&lt;h4>Results&lt;/h4>Non-polymorphic copy number variants (CNVs) were identified in 1512 patients (30%) and 615 (32%) present in 552 patients (11%) were classified as pathogenic. CNVs were analysed according to type, size, inheritance pattern, distribution am</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2025-04-05T00:43:19.489Z</modification><creation>2021-02-20T07:27:50Z</creation></dates><accession>S-EPMC6978242</accession><cross_references><pubmed>31851782</pubmed><doi>10.1002/mgg3.1056</doi></cross_references></HashMap>